ARTV

10.60

6.11% -0.69

Pre-mercato: 12.10 1.50 +14.15%

Artiva Biotherapeutics Inc (ARTV)

Panoramica Notizia Cronologia dei prezzi Forum Previsione

Precedente Chiudi:

$11.29

Aprire:

$11.16

Volume 24 ore:

152.88K

Relative Volume:

0.68

Capitalizzazione di mercato:

$262.00M

Reddito:

$251.00K

Utile/perdita netta:

$-83.87M

Rapporto P/E:

-3.0896

EPS:

-3.4309

Flusso di cassa netto:

$-79.34M

1 W Prestazione:

+16.87%

1M Prestazione:

+57.27%

6M Prestazione:

+208.14%

1 anno Prestazione:

+379.64%

Intervallo 1D:

$10.53

$11.37

Intervallo di 1 settimana:

$8.52

$11.60

Portata 52W:

$1.47

$14.53

Artiva Biotherapeutics Inc Stock (ARTV) Company Profile

Nome

Artiva Biotherapeutics Inc

Settore

Healthcare (1106)

Industria

Biotechnology (615)

Telefono

(858) 267-4467

Indirizzo

5505 MOREHOUSE DRIVE, SAN DIEGO

Dipendente

104

Cinguettio

Prossima data di guadagno

2026-05-14

Ultimi documenti SEC

ARTV's Discussions on Twitter

Compare ARTV vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ARTV Artiva Biotherapeutics Inc	10.60	262.00M	251.00K	-83.87M	-79.34M	-3.4309
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

Artiva Biotherapeutics Inc Stock (ARTV) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-11	Ripresa	H.C. Wainwright	Buy
2024-12-30	Iniziato	H.C. Wainwright	Buy
2024-08-13	Iniziato	Cantor Fitzgerald	Overweight
2024-08-13	Iniziato	Jefferies	Buy
2024-08-13	Iniziato	Needham	Buy
2024-08-13	Iniziato	TD Cowen	Buy
2024-08-13	Iniziato	Wedbush	Outperform

Mostra tutto

Artiva Biotherapeutics Inc Borsa (ARTV) Ultime notizie

May 05, 2026

Why Artiva Bio (ARTV) could be the turning point you've been waiting for (Gains) 2026-05-05Technical Analysis - Newser

May 05, 2026

May 04, 2026

Artiva Biotherapeutics Inc expected to post a loss of 87 cents a shareEarnings Preview - TradingView

May 04, 2026

Apr 30, 2026

Artiva Biotherapeutics | 10-K/A: Annual report (Amendment) - Moomoo

Apr 30, 2026

Executive pay and ownership detailed in Artiva Biotherapeutics (NASDAQ: ARTV) 10-K/A - Stock Titan

Apr 30, 2026

Apr 28, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 28, 2026

Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape - GlobeNewswire Inc.

Apr 28, 2026

Apr 24, 2026

Deep B-Cell Depletion: The Next Wave In Autoimmune Diseases With Artiva's AlloNK In Focus - RTTNews

Apr 24, 2026

Apr 22, 2026

Sonoco Products Posts Downbeat Q1 Results, Joins Target Hospitality, Calix And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm

Apr 22, 2026

Apr 21, 2026

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 21, 2026

Apr 20, 2026

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Apr 20, 2026

Apr 17, 2026

Is Artiva Biotherapeutics (NASDAQ:ARTV) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Apr 17, 2026

Apr 15, 2026

Artiva Biotherapeutics Spotlights RA as Lead NK Cell Program, Eyes H1 Efficacy Data Catalyst at Needham - MarketBeat

Apr 15, 2026

ARTV: Advancing scalable NK cell therapy for RA, targeting deep, durable responses in refractory patients - TradingView

Apr 15, 2026

Apr 12, 2026

Artiva Biotherapeutics (NASDAQ:ARTV) Stock Rating Lowered by Wall Street Zen - MarketBeat

Apr 12, 2026

Apr 10, 2026

Whale Trades: Is Blend Labs Inc backed by strong institutional buying2026 Setups & Long-Term Capital Growth Strategies - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference - Sahm

Apr 09, 2026

Apr 08, 2026

Can Artiva Bio (ARTV) Stock Reach New Highs | Price at $6.37, Down 4.50%Crowd Breakout Signals - Newser

Apr 08, 2026

Apr 06, 2026

Should I Buy Artiva Bio (ARTV) Stock Now | Price at $7.29, Up 8.16%Expert Stock Picks - Newser

Apr 06, 2026

Apr 04, 2026

ARTV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026

Artiva Biotherapeutics (NASDAQ:ARTV) Rating Increased to Hold at Wall Street Zen - MarketBeat

Apr 04, 2026

Apr 03, 2026

ARTV Stock Analysis: Bearish Pressure Amid Market Decline - Newser

Apr 03, 2026

Apr 02, 2026